Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Aims: Dystroglycan is an important structural and signalling protein that is expressed in most human cells. α-Dystroglycan has been investigated and found to be reduced in human cancers, but there is only one published study on the expression of β-dystroglycan in human cancer and that was only on small numbers of breast and prostatic cancers. The aim was to conduct a comprehensive immunohistochemical survey of the expression of β-dystroglycan in normal human tissues and common cancers. Methods and results: Triplicate tissue microarrays of 681 samples of normal human tissues and common cancers were stained using an antibody directed against the cytoplasmic component of β-dystroglycan. β-Dystroglycan was strongly expressed at the intercellular junctions and basement membranes of all normal human epithelia. Expression of β-dystroglycan was absent or markedly reduced in 100% of oesophageal adenocarcinomas, 97% of colonic cancers, 100% of transitional cell carcinomas of the urothelium and 94% of breast cancers. In the breast cancers, the only tumours that showed any retention of β-dystroglycan expression were small low-grade oestrogen receptor-positive tumours. The only cancers that showed retention of β-dystroglycan expression were cutaneous basal cell carcinomas. Conclusions: There is loss or marked reduction of β-dystroglycan expression (by immunohistochemistry) in the vast majority of human cancers surveyed. Since β-dystroglycan is postulated to have a tumour suppressor effect, this loss may have important functional significance. © 2008 The Authors.

Original publication

DOI

10.1111/j.1365-2559.2008.03157.x

Type

Journal article

Journal

Histopathology

Publication Date

01/11/2008

Volume

53

Pages

561 - 566